Trinity Biotech PLC logo

Trinity Biotech PLC - ADR

FRA:TRB (Ireland)   ADR
€ 2.12 (0%) Mar 28
At Loss
Market Cap:
€ 16.20M ($ 17.45M)
Enterprise V:
€ 72.34M ($ 77.94M)
Volume:
-
Avg Vol (2M):
327.00
Also Trade In:

Business Description

Trinity Biotech PLC logo
Trinity Biotech PLC
NAICS : 325413 SIC : 2835
ISIN : US8964383066

Share Class Description:

FRA:TRB: ADR
Description
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.
Name Current Vs Industry Vs History
Cash-To-Debt 0.09
Equity-to-Asset -0.28
Debt-to-Equity -3.83
Debt-to-EBITDA -2.54
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.58
Distress
Grey
Safe
Beneish M-Score -3.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 23.39
9-Day RSI 38.56
14-Day RSI 44.59
6-1 Month Momentum % -36.72
12-1 Month Momentum % -46.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.44
Quick Ratio 1.8
Cash Ratio 0.49
Days Inventory 174.9
Days Sales Outstanding 74.08
Days Payable 89.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -22.2
Shareholder Yield % 15.59

Financials (Next Earnings Date:2024-07-05 Est.)

FRA:TRB's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Trinity Biotech PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 66.847
EPS (TTM) (€) -3.501
Beta 0.89
Volatility % 60.89
14-Day RSI 44.59
14-Day ATR (€) 0.018933
20-Day SMA (€) 2.12
12-1 Month Momentum % -46.33
52-Week Range (€) 1.69 - 4.775
Shares Outstanding (Mil) 7.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Trinity Biotech PLC Filings

Filing Date Document Date Form
No Filing Data

Trinity Biotech PLC Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Trinity Biotech PLC Frequently Asked Questions

What is Trinity Biotech PLC(FRA:TRB)'s stock price today?
The current price of FRA:TRB is €2.12. The 52 week high of FRA:TRB is €4.78 and 52 week low is €1.69.
When is next earnings date of Trinity Biotech PLC(FRA:TRB)?
The next earnings date of Trinity Biotech PLC(FRA:TRB) is 2024-07-05 Est..
Does Trinity Biotech PLC(FRA:TRB) pay dividends? If so, how much?
Trinity Biotech PLC(FRA:TRB) does not pay dividend.

Press Release

Subject Date
No Press Release